Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Rachel Ann Jones has worked on the following 4 EPO patent applications which have been published in the last five years:

EP13844762

PEPTIDES, DEVICES, AND METHODS FOR THE DETECTION OF EHRLICHIA ANTIBODIES

IPC classification:
G01N 33/53, G01N 33/554, G01N 33/567
Agent:
Rachel Ann Jones, Mewburn Ellis LLP
Agent:
Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP15803007

SOLUBLE BACTERIAL AND FUNGAL PROTEINS AND METHODS AND USES THEREOF IN INHIBITING AND DISPERSING BIOFILM

IPC classification:
A01N 63/00, A01P 1/00, A01P 3/00, A61K 38/16, A61L 2/16, A61L 27/22, A61L 27/54, A61L 31/00, A61L 31/10, A61L 31/16, C12N 7/01, C12N 9/24, C12N 15/56, C12N 15/63, C12N 15/80
Applicant:
McGill University - Office of Sponsored Research
Applicant:
The Hospital For Sick Children
Agent:
Rachel Ann Jones, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15845094

RECOMBINANT FUSION PROTEIN FORMULATION

IPC classification:
A61K 39/395, A61K 47/02, A61K 47/10, A61K 47/18, A61K 47/22, A61K 47/26, A61P 27/02
Agent:
Rachel Ann Jones, Mewburn Ellis LLP
Status:
Request for examination was made
EP15844336

RECOMBINANT FUSION PROTEIN FORMULATION

IPC classification:
A61K 38/17, A61P 27/02, C07K 14/71, C07K 19/00
Agent:
Rachel Ann Jones, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature